Citizens Maintains Market Outperform on Exelixis, Raises Price Target to $65

Benzinga · 3d ago
Citizens analyst Silvan Turkcan maintains Exelixis (NASDAQ:EXEL) with a Market Outperform and raises the price target from $55 to $65.